SCHEMBL6953374

SCHEMBL6953374

CCCC1=NN(c2ccc([N+](=O)[O-])cc2)C(=O)/C1=C\Nc1ccccc1CC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 13/20 0.62
KMT2A Q03164 13/20 0.62
MAPT P10636 11/20 0.62
ALDH1A1 P00352 10/20 0.62
POLB P06746 2/20 0.62
HTT P42858 2/20 0.62
NPC1 O15118 3/20 0.45
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
KDM4E B2RXH2 3/20 0.45
RAB9A P51151 2/20 0.45
ALOX12 P18054 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
ABCG2 Q9UNQ0 4/20 0.43
PKM P14618 1/20 0.43
AMY1A P0DUB6 1/20 0.41
MCOLN3 Q8TDD5 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953377 1.00 MEN1 (0.62) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL8427586 0.95 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL8427585 0.95 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL8009336 0.88 MAPT (0.48) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL8009339 0.88 MAPT (0.48) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL8009348 0.88 MAPT (0.48) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL6952081 0.88 MAPT (0.47) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL6952087 0.88 MAPT (0.47) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL6952078 0.88 MAPT (0.47) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL8008868 0.87 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0930881-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GmbH (DE) 1999-07-28 EP disclosed
WO-1998016224-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GMBH (DE) 1998-04-23 WO disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed